However, utilizing FACS-sorting and EGC-specific genetic IL-6 and IL-1R depletion models, we confirmed the critical role of IL-1-triggered EGC-IL-6 release as a regulator of tumor growth and SPP1+ TAM differentiation. The gene discussed is IL1R1; the disease is neoplasm.